Clinical experience with Ancrod in acute ischaemic stroke.
Nuber
R
R
BASF Pharma/Knoll AG, Clinical Development, Ludwigshafen, Germany. richard.nuber@knoll-ag.de
D000368:Aged; D000721:Ancrod / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D004311:Double-Blind Method; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D020521:Stroke / Q000188:drug therapy*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D000721:Ancrod